<p>908 Devices（纳斯达克：MASS - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 从 “持有” 评级上调至 “买入” 评级。</p>
<p>另外，Weiss Ratings 在 1 月 21 日的报告中重新发布了对 908 Devices 股票的 “卖出（d-）” 评级。一位股票研究分析师给予该股票 “买入” 评级，另一位则给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，共识目标价为 12.00 美元。</p>
<p><strong>查看我们关于 908 Devices 的最新股票报告</strong></p>
<h2>908 Devices 价格表现</h2>
<p>周五，MASS 的开盘价为 6.07 美元。该公司的 50 日简单移动平均为 6.32 美元，200 日简单移动平均为 6.64 美元。该公司的市值为 2.269 亿美金，市盈率为 11.04，贝塔值为 0.47。908 Devices 的 1 年低点为 3.55 美元，1 年高点为 9.34 美元。</p>
<p>908 Devices（纳斯达克：MASS - 获取免费报告）最后一次公布季度财报是在 3 月 3 日，报告显示该季度每股收益为（0.05）美元，超出共识预期的（0.06）美元 0.01 美元。908 Devices 的净利润率为 34.68%，股本回报率为负的 14.99%。该公司该季度的收入为 1738 万美元，而共识预期为 1619 万美元。股票分析师预计 908 Devices 在当前年度的每股收益将为-1.99 美元。</p>
<h2>内部活动</h2>
<p>在其他消息中，首席财务官 Joseph H. Iv Griffith 在 2 月 2 日的交易中出售了 23,175 股公司的股票。股票以平均价格 6.18 美元出售，总价值为 143,221.50 美元。交易后，首席财务官持有公司 139,896 股股票，价值约为 864,557.28 美元。此次交易使其持股减少了 14.21%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。目前，23.70% 的股票由内部人士持有。</p>
<h2>对 908 Devices 的对冲基金看法</h2>
<p>几家机构投资者最近买入和卖出了该股票的股份。First Light Asset Management LLC 在第四季度将其在 908 Devices 的持股增加了 92.6%。First Light Asset Management LLC 现在拥有 4,836,186 股公司股票，价值 2539 万美元，此前在上个季度购买了额外的 2,325,690 股。GM Advisory Group LLC 在第二季度购买了 908 Devices 的新头寸，价值约 830.9 万美元。Needham Investment Management LLC 在第四季度将其在 908 Devices 的持股增加了 246.8%。Needham Investment Management LLC 现在拥有 770,000 股公司股票，价值 404.2 万美元，此前在上个季度购买了额外的 548,000 股。Marshall Wace LLP 在第二季度将其在 908 Devices 的持股增加了 359.4%。Marshall Wace LLP 现在拥有 648,796 股公司股票，价值 462.6 万美元，此前在上个季度购买了额外的 507,562 股。最后，First Eagle Investment Management LLC 在第三季度将其在 908 Devices 的持股增加了 125.9%。First Eagle Investment Management LLC 现在拥有 603,962 股公司股票，价值 529.1 万美元，此前在上个季度购买了额外的 336,584 股。88.06% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>908 Devices 公司简介</h2>
<p>（获取免费报告）</p>
<p>908 Devices Inc（纳斯达克：MASS）是一家开发和制造便携式分析仪器的公司，旨在提供快速的化学检测，适用于现场和实验室环境。该公司的核心重点在于小型化高性能质谱和离子迁移谱技术，使用户能够进行现场分析，而传统上需要台式设备。</p>
<p>908 Devices 产品组合中的关键产品包括 MX908，一种手持式高分辨率质谱仪，能够检测和识别广泛的化学物质和爆炸物；M908 便携式质谱仪，适用于实验室或移动单元；以及 ZipChip 毛细管电泳系统，用于高通量微流体分离。</p>
<h2>相关文章</h2>
<ul>
<li>五只我们更看好的股票超过 908 Devices</li>
<li>Martin Weiss 的个人警告（请阅读）</li>
<li>SpaceX IPO 确认：立即索取您的股份</li>
<li>这枚硬币一切都在向好发展</li>
<li>今天只有 500 人……</li>
<li>华尔街害怕的黄金图表……</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 908 Devices 吗？</h2>
<p>在考虑 908 Devices 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 908 Devices 并不在名单上。</p>
<p>虽然 908 Devices 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

MASS

<p>华尔街禅将 908 Devices（NASDAQ:MASS）的评级从 “持有” 上调至 “买入”。该公司的平均评级为 “持有”，共识目标价为 12.00 美元。908 Devices 报告的季度每股收益为（0.05 美元），超出预期，收入为 1738 万美元。首席财务官 Joseph H. Iv Griffith 最近出售了 23,175 股。机构投资者持有该公司 88.06% 的股份。908 Devices 专注于化学检测的便携式分析仪器</p>

<p>908 Devices (NASDAQ:MASS - Get Free Report) was upgraded by Wall Street Zen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report issued on Saturday.</p>
<div class="lb-trans"><p>908 Devices（纳斯达克：MASS - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 从 “持有” 评级上调至 “买入” 评级。</p>
</div><p>Separately, Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of 908 Devices in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of &#34;Hold&#34; and a consensus price target of $12.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 1 月 21 日的报告中重新发布了对 908 Devices 股票的 “卖出（d-）” 评级。一位股票研究分析师给予该股票 “买入” 评级，另一位则给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，共识目标价为 12.00 美元。</p>
</div><p><strong>View Our Latest Stock Report on 908 Devices</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 908 Devices 的最新股票报告</strong></p>
</div><h2>908 Devices Price Performance</h2>
<div class="lb-trans"><h2>908 Devices 价格表现</h2>
</div><p>MASS opened at $6.07 on Friday. The company has a 50 day simple moving average of $6.32 and a two-hundred day simple moving average of $6.64. The firm has a market cap of $226.90 million, a P/E ratio of 11.04 and a beta of 0.47. 908 Devices has a 1-year low of $3.55 and a 1-year high of $9.34.</p>
<div class="lb-trans"><p>周五，MASS 的开盘价为 6.07 美元。该公司的 50 日简单移动平均为 6.32 美元，200 日简单移动平均为 6.64 美元。该公司的市值为 2.269 亿美金，市盈率为 11.04，贝塔值为 0.47。908 Devices 的 1 年低点为 3.55 美元，1 年高点为 9.34 美元。</p>
</div><p>908 Devices (NASDAQ:MASS - Get Free Report) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. The firm had revenue of $17.38 million for the quarter, compared to the consensus estimate of $16.19 million. Equities analysts anticipate that 908 Devices will post -1.99 earnings per share for the current year.</p>
<div class="lb-trans"><p>908 Devices（纳斯达克：MASS - 获取免费报告）最后一次公布季度财报是在 3 月 3 日，报告显示该季度每股收益为（0.05）美元，超出共识预期的（0.06）美元 0.01 美元。908 Devices 的净利润率为 34.68%，股本回报率为负的 14.99%。该公司该季度的收入为 1738 万美元，而共识预期为 1619 万美元。股票分析师预计 908 Devices 在当前年度的每股收益将为-1.99 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other news, CFO Joseph H. Iv Griffith sold 23,175 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $6.18, for a total value of $143,221.50. Following the transaction, the chief financial officer owned 139,896 shares of the company's stock, valued at approximately $864,557.28. The trade was a 14.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. 23.70% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他消息中，首席财务官 Joseph H. Iv Griffith 在 2 月 2 日的交易中出售了 23,175 股公司的股票。股票以平均价格 6.18 美元出售，总价值为 143,221.50 美元。交易后，首席财务官持有公司 139,896 股股票，价值约为 864,557.28 美元。此次交易使其持股减少了 14.21%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。目前，23.70% 的股票由内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On 908 Devices</h2>
<div class="lb-trans"><h2>对 908 Devices 的对冲基金看法</h2>
</div><p>Several institutional investors have recently bought and sold shares of the stock. First Light Asset Management LLC lifted its stake in 908 Devices by 92.6% in the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company's stock worth $25,390,000 after purchasing an additional 2,325,690 shares in the last quarter. GM Advisory Group LLC purchased a new position in shares of 908 Devices during the second quarter valued at about $8,309,000. Needham Investment Management LLC increased its holdings in shares of 908 Devices by 246.8% in the fourth quarter. Needham Investment Management LLC now owns 770,000 shares of the company's stock worth $4,042,000 after purchasing an additional 548,000 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of 908 Devices by 359.4% in the second quarter. Marshall Wace LLP now owns 648,796 shares of the company's stock worth $4,626,000 after purchasing an additional 507,562 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its position in shares of 908 Devices by 125.9% in the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company's stock worth $5,291,000 after buying an additional 336,584 shares in the last quarter. 88.06% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者最近买入和卖出了该股票的股份。First Light Asset Management LLC 在第四季度将其在 908 Devices 的持股增加了 92.6%。First Light Asset Management LLC 现在拥有 4,836,186 股公司股票，价值 2539 万美元，此前在上个季度购买了额外的 2,325,690 股。GM Advisory Group LLC 在第二季度购买了 908 Devices 的新头寸，价值约 830.9 万美元。Needham Investment Management LLC 在第四季度将其在 908 Devices 的持股增加了 246.8%。Needham Investment Management LLC 现在拥有 770,000 股公司股票，价值 404.2 万美元，此前在上个季度购买了额外的 548,000 股。Marshall Wace LLP 在第二季度将其在 908 Devices 的持股增加了 359.4%。Marshall Wace LLP 现在拥有 648,796 股公司股票，价值 462.6 万美元，此前在上个季度购买了额外的 507,562 股。最后，First Eagle Investment Management LLC 在第三季度将其在 908 Devices 的持股增加了 125.9%。First Eagle Investment Management LLC 现在拥有 603,962 股公司股票，价值 529.1 万美元，此前在上个季度购买了额外的 336,584 股。88.06% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>908 Devices Company Profile</h2>
<div class="lb-trans"><h2>908 Devices 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>908 Devices Inc NASDAQ: MASS is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.</p>
<div class="lb-trans"><p>908 Devices Inc（纳斯达克：MASS）是一家开发和制造便携式分析仪器的公司，旨在提供快速的化学检测，适用于现场和实验室环境。该公司的核心重点在于小型化高性能质谱和离子迁移谱技术，使用户能够进行现场分析，而传统上需要台式设备。</p>
</div><p>Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.</p>
<div class="lb-trans"><p>908 Devices 产品组合中的关键产品包括 MX908，一种手持式高分辨率质谱仪，能够检测和识别广泛的化学物质和爆炸物；M908 便携式质谱仪，适用于实验室或移动单元；以及 ZipChip 毛细管电泳系统，用于高通量微流体分离。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than 908 Devices</li>
<li>A personal warning from Martin Weiss (Please read)</li>
<li>SpaceX IPO Confirmed: Claim Your Stake Today</li>
<li>This coin has everything going for it</li>
<li>Only 500 people today…</li>
<li>The gold chart Wall Street is terrified of…</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 908 Devices</li>
<li>Martin Weiss 的个人警告（请阅读）</li>
<li>SpaceX IPO 确认：立即索取您的股份</li>
<li>这枚硬币一切都在向好发展</li>
<li>今天只有 500 人……</li>
<li>华尔街害怕的黄金图表……</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in 908 Devices Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 908 Devices 吗？</h2>
</div><p>Before you consider 908 Devices, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 908 Devices 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 908 Devices wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 908 Devices 并不在名单上。</p>
</div><p>While 908 Devices currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 908 Devices 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

908 Devices（NASDAQ:MASS）在 Wall Street Zen 的评级被提升至买入